Flubendazole Plays an Important Anti-Tumor Role in Different Types of Cancers

Int J Mol Sci. 2022 Jan 4;23(1):519. doi: 10.3390/ijms23010519.

Abstract

Flubendazole, belonging to benzimidazole, is a broad-spectrum insect repellent and has been repurposed as a promising anticancer drug. In recent years, many studies have shown that flubendazole plays an anti-tumor role in different types of cancers, including breast cancer, melanoma, prostate cancer, colorectal cancer, and lung cancer. Although the anti-tumor mechanism of flubendazole has been studied, it has not been fully understood. In this review, we summarized the recent studies regarding the anti-tumor effects of flubendazole in different types of cancers and analyzed the related mechanisms, in order to provide the theoretical reference for further studies in the future.

Keywords: anti-tumor role; breast cancer; flubendazole; melanoma; prostate cancer.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Clinical Studies as Topic
  • Drug Evaluation, Preclinical
  • Drug Monitoring
  • Drug Resistance, Neoplasm
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Mebendazole / analogs & derivatives*
  • Mebendazole / chemistry
  • Mebendazole / pharmacology
  • Mebendazole / therapeutic use
  • Neoplasms / drug therapy
  • Neoplasms / etiology
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Organ Specificity / drug effects
  • Signal Transduction
  • Treatment Outcome
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Mebendazole
  • flubendazole